Capricor Therapeutics
CAPR
#7735
Rank
C$0.66 B
Marketcap
C$11.47
Share price
21.91%
Change (1 day)
25.36%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -C$0.16 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$0.15 Billion a decrease over its 2024 earnings that were of -C$55.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.16 Billion8.72%
2025 -C$0.15 Billion159.57%
2024 -C$55.98 Million81.57%
2023 -C$30.83 Million-23.2%
2022 -C$40.15 Million44.93%
2021 -C$27.7 Million46.61%
2020 -C$18.9 Million78.71%
2019 -C$10.58 Million-49.7%
2018 -C$21.02 Million-724.78%
2017 C$3.36 M-112.93%
2016 -C$26.02 Million46.27%
2015 -C$17.79 Million106.82%
2014 -C$8.6 Million-48.41%
2013 -C$16.67 Million977.23%
2012 -C$1.55 Million-77.11%
2011 -C$6.76 Million-22.35%
2010 -C$8.71 Million-20.17%
2009 -C$10.91 Million-41.17%
2008 -C$18.54 Million41.05%
2007 -C$13.15 Million1098.87%
2006 -C$1.1 Million4101.55%
2005 -C$0.03 Million-0.97%
2004 -C$0.03 Million17.87%
2003 -C$0.03 Million3.66%
2002 -C$0.03 Million-30.11%
2001 -C$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.93 B-22,770.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.10 B-797.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-C$1.15 Billion 623.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.43 Billion 169.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$8.64 Million-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$20.64 Million-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA